Jun. 23 at 9:35 PM
$JANX JANX Janux Therapeutics discloses the departure of Chief Medical Officer William Go (14.91 +0.57)
On June 23, 2026, William Go departed as Chief Medical Officer of Janux Therapeutics under circumstances that the company determined to constitute a termination without "Cause" under the terms of the company's change in control and severance benefit plan.
Co has initiated a search for his successor. In the interim, responsibilities previously overseen by Dr. Go will be assumed by members of the company's existing clinical leadership team. The transition does not affect the company's development strategy, regulatory plans, or previously disclosed clinical timelines.
